Filing metadata

Accession number
0001567619-22-011721
Form type
Form 4
Filer
4D Molecular Therapeutics, Inc.
CIK
CIK 1650648
Filed
May 25, 2022
Reporting period
May 23, 2022
Description
Insider transaction

Explore SEC Filings Hub